UC-MSC Cell Therapy Study for Systemic Lupus Erythematosus (SLE) Patients

Abroad (travel likely)RecruitingPHASE1

Conditions

SLE · Lupus · Systemic Lupus Erthematosus · Systemic Lupus Erythematosus · Systemic Lupus Erythematosus (SLE)

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Medical University of South Carolina, Charleston, South Carolina, United States
Contact: Study coordinator (Stephanie Dezzutti) · lupusresearch@musc.edu · 866-859-6107
Contact: Principal Investigator (Kathleen Maksimowicz McKinnon, MD)

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

A Study to Evaluate the Safety and Activity of SAR448501/DR-0201 in Patients With Autoimmune Rheumatic Diseases

Systemic Lupus Erythematosus (SLE) · Rheumatoid Arthritis (RA)

Abroad (travel likely)RecruitingPHASE1

Brisbane, Australia · Melbourne, Australia

A Clinical Study of YTS109 Cell for R/R Autoimmune Diseases

Systemic Lupus Erythematosus (SLE) · Lupus Nephritis (LN) · Systemic Sclerosis (SSc)

Abroad (travel likely)RecruitingPHASE1

Hefei, China

Exploratory Clinical Study on YTS109 Cell Therapy for Autoimmune Diseases

Systemic Lupus Erythematosus (SLE) · Systemic Sclerosis · Sjogren's Syndrome (SS)

Abroad (travel likely)RecruitingPHASE1

Xuzhou, China · Xuzhou, China

A Clinical Study of TI-0032-III Injection in Patients With Relapsed and Refractory Autoimmune Diseases

Systemic Lupus Erythematosus (SLE) · Sjogren's Syndrome (SS) · Systemic Sclerosis (SSc)

Abroad (travel likely)RecruitingPHASE1

Shanghai, China